Mandeep Kumar Arora Masters in Pharmacology (ISF College of Pharmacy); B.Pharmacy (Maharastra College of Pharmacy)
Professor, DIT University, Dehradun, Uttarakhand · India
Editorial leadership for Journal of Bioinformatics And Diabetes ISSN 2374-9431
Research interests
- Cardiovascular Pharmacology
Biography
Mandeep Kumar Arora is a Professor at DIT University, Dehradun, Uttarakhand, India. He received his education from ISF College of Pharmacy and Maharastra College of Pharmacy. His research focuses on the molecular mechanisms and pathophysiology of diabetic nephropathy, including the involvement of multifaceted signalling pathways, oxidative stress, and NADPH-mediated ROS-RNS, as well as pharmacotherapeutic interventions such as PPAR ligands, fenofibrate, rosiglitazone, and DPP4 inhibitors in managing diabetic complications. He has also investigated the cardiovascular effects of chronic 17β-ethinyl estradiol use and contributed to COVID-19 treatment research, notably through his highly cited work on molnupiravir, "Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19" (2021), which has received 163 citations. Professor Arora has authored 14 or more indexed publications spanning diabetes, nephropathy, and therapeutic development.
Selected publications
- Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19 2021 cited 163×
- Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects 2023 cited 33×
- MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature 2022 cited 29×
- Plumbagin Alleviates Intracerebroventricular-Quinolinic Acid Induced Depression-like Behavior and Memory Deficits in Wistar Rats 2022 cited 19×
- Natural cationic polymer-derived injectable hydrogels for targeted chemotherapy 2023 cited 15×
- Insights on the role of anti-inflammatory and immunosuppressive agents in the amelioration of diabetes 2022 cited 8×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JBD for your work?
This journal is guided by Mandeep Kumar Arora (Professor, DIT University, Dehradun, Uttarakhand) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.